Center for Scientific Review; Notice of Closed Meetings, 37234-37235 [2017-16730]
Download as PDF
37234
Federal Register / Vol. 82, No. 152 / Wednesday, August 9, 2017 / Notices
Medicare Access and CHIP
Reauthorization Act of 2015, 42 U.S.C
1395ee. This Committee is also
governed by provisions of the Federal
Advisory Committee Act, as amended (5
U.S.C App.), which sets forth standards
for the formation and use of federal
advisory committees. In accordance
with its statutory mandate, the
Committee is to review physicianfocused payment model proposals and
prepare recommendations regarding
whether such models meet criteria that
were established through rulemaking by
the Secretary of Health and Human
Services (the Secretary). The Committee
is composed of 11 members appointed
by the Comptroller General.
II. Agenda
At the September 7–8, 2017, the
Committee will hear presentations on
PFPMs that are ready for Committee
deliberation. The presentations will be
followed by public comment and
Committee deliberation. If the
Committee completes deliberations,
voting will occur on recommendations
to the Secretary of Health and Human
Services. There will be time allocated
for public comment on agenda items.
Documents will be posted on the
Committee Web site and distributed on
the Committee listserv prior to the
public meeting. The agenda is subject to
change. If the agenda does change, we
will inform registrants and update our
Web site to reflect any changes.
III. Meeting Attendance
The meeting is open to the public.
The public may also attend via
conference call or view the meeting via
livestream at www.hhs.gov/live. The
conference call dial-in information will
be sent to registrants prior to the
meeting.
sradovich on DSK3GMQ082PROD with NOTICES
Meeting Registration
The public may attend the meetings
in-person or participate by phone via
audio teleconference. Space is limited
and registration is preferred in order to
attend in-person or by phone.
Registration may be completed online at
www.regonline.com/PTACMeetings
Registration.
The following information is
submitted when registering:
Name:
Company/organization name:
Postal address:
Email address:
Persons wishing to attend this
meeting must register by following the
instructions in the ‘‘Meeting
Registration’’ section of this notice. A
confirmation email will be sent to
VerDate Sep<11>2014
17:00 Aug 08, 2017
Jkt 241001
registrants shortly after completing the
registration process.
IV. Special Accommodations
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact
Angela Tejeda, no later than August 24,
2017. Please submit your requests by
email to Angela.Tejeda@hhs.gov or by
calling 202–401–8297.
V. Copies of the PTAC Charter and
Meeting Material
The Secretary’s Charter for the
Physician-Focused Payment Model
Technical Advisory Committee is
available on the ASPE Web site at
https://aspe.hhs.gov/charter-physicianfocused-payment-model-technicaladvisory-committee.
Additional material for this meeting
can be found on the PTAC Web site. For
updates and announcements, please use
the link to subscribe to the PTAC email
listserv.
Dated: August 3, 2017.
John R. Graham,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2017–16784 Filed 8–8–17; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Informatics Support for NIDA (8940).
Date: August 31, 2017.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: August 3, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16733 Filed 8–8–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA–MH–
17–650: Implementation Science for the
Prevention and Treatment of Mental and/or
Substance Use Disorders in Low- and
Middle-income Countries (U01).
Date: September 4–5, 2017.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: President Hotel, 4 Alexander Road,
Bantry Bay, Cape Town, 8001, South Africa.
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–17–
076: High-End Instrumentation (HEI) Grant
Program (S10).
Date: September 12, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Songtao Liu, MD,
Scientific Review Officer, Center for
E:\FR\FM\09AUN1.SGM
09AUN1
Federal Register / Vol. 82, No. 152 / Wednesday, August 9, 2017 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
Bethesda, MD 20817, 301–435–3578,
songtao.liu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 3, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16730 Filed 8–8–17; 8:45 am]
BILLING CODE 4140–01–P
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: August 3, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16732 Filed 8–8–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute; Notice of Meeting
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Heart, Lung,
and Blood Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
National Center for Advancing
Translational Sciences; Notice of
Meetings
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: September 12, 2017.
Open: 12:00 p.m. to 5:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 35A, Porter Building, Room 640,
35A Convent Drive, Bethesda, MD 20892.
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, 301–435–0260, moenl@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
VerDate Sep<11>2014
17:00 Aug 08, 2017
Jkt 241001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Center for
Advancing Translational Sciences.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cures Acceleration
Network Review Board.
Date: September 7, 2017.
Time: 8:30 a.m. to 3:00 p.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
37235
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: September 7, 2017.
Open: 8:30 a.m. to 3:00 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Closed: 3:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 3, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16731 Filed 8–8–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be open to the
public as indicated below, with a short
public comment period at the end.
Attendance is limited by the space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will also be videocast and can
be accessed from the NIH Videocasting
E:\FR\FM\09AUN1.SGM
09AUN1
Agencies
[Federal Register Volume 82, Number 152 (Wednesday, August 9, 2017)]
[Notices]
[Pages 37234-37235]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16730]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA-MH-17-650: Implementation Science for the Prevention and
Treatment of Mental and/or Substance Use Disorders in Low- and
Middle-income Countries (U01).
Date: September 4-5, 2017.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: President Hotel, 4 Alexander Road, Bantry Bay, Cape Town,
8001, South Africa.
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR-17-076: High-End Instrumentation (HEI) Grant Program
(S10).
Date: September 12, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Songtao Liu, MD, Scientific Review Officer,
Center for
[[Page 37235]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5108, Bethesda, MD 20817, 301-435-3578,
songtao.liu@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: August 3, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-16730 Filed 8-8-17; 8:45 am]
BILLING CODE 4140-01-P